These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21511884)

  • 1. The diversity of sex steroid action: regulation of metabolism by estrogen signaling.
    Faulds MH; Zhao C; Dahlman-Wright K; Gustafsson JÅ
    J Endocrinol; 2012 Jan; 212(1):3-12. PubMed ID: 21511884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic impact of estrogen signalling through ERalpha and ERbeta.
    Foryst-Ludwig A; Kintscher U
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):74-81. PubMed ID: 20599505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
    Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.
    Hegarty BD; Turner N; Cooney GJ; Kraegen EW
    Acta Physiol (Oxf); 2009 May; 196(1):129-45. PubMed ID: 19245658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of estrogen receptors in the control of energy and glucose homeostasis.
    Ropero AB; Alonso-Magdalena P; Quesada I; Nadal A
    Steroids; 2008 Oct; 73(9-10):874-9. PubMed ID: 18249429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes.
    Nadal A; Alonso-Magdalena P; Soriano S; Quesada I; Ropero AB
    Mol Cell Endocrinol; 2009 May; 304(1-2):63-8. PubMed ID: 19433249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early obesity and age-related mimicry of metabolic syndrome in female mice with sex hormonal imbalances.
    Sairam MR; Wang M; Danilovich N; Javeshghani D; Maysinger D
    Obesity (Silver Spring); 2006 Jul; 14(7):1142-54. PubMed ID: 16899795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
    Diamant M
    Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome: role of skeletal muscle metabolism.
    Stump CS; Henriksen EJ; Wei Y; Sowers JR
    Ann Med; 2006; 38(6):389-402. PubMed ID: 17008303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome.
    Aguilera CM; Gil-Campos M; Cañete R; Gil A
    Clin Sci (Lond); 2008 Feb; 114(3):183-93. PubMed ID: 18184112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and insulin metabolism in obese youth.
    Burgert TS
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():555-9. PubMed ID: 17237742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.